We are live on ! Find out more
CLLS

Cellectis
CLLS

38 hedge funds and large institutions have $184M invested in Cellectis in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 9

4% more capital invested

Capital invested by funds: $176M → $184M (+$7.92M)

14% less funds holding

Funds holding: 44 → 38 (-6)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
38
Holders Change
-6
Holders Change %
-13.64%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
15
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$5.29M
2
Millennium Management
Millennium Management
New York
+$4.32M
3
THSP
Taube Hodson Stonex Partners
United Kingdom
+$2.92M
4
CWM
Cabot Wealth Management
Massachusetts
+$929K
5
CAM
Cormorant Asset Management
Massachusetts
+$849K

Top Sellers

Rank Fund Capital Flow
1
VIA
Vident Investment Advisory
Georgia
-$722K
2
Citadel Advisors
Citadel Advisors
Florida
-$625K
3
NIP
Nicholas Investment Partners
California
-$513K
4
TI
Trexquant Investment
Connecticut
-$347K
5
DAM
Deltec Asset Management
New York
-$330K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$427K +$40K +1,366 +9%
GH
27
GAM Holding
Switzerland
$405K +$170K +5,810 +62%
HighTower Advisors
28
HighTower Advisors
Illinois
$357K +$1.17K +40 +0.3%
ARTA
29
A.R.T. Advisors
New York
$355K -$135K -4,600 -26%
OC
30
Oppenheimer & Co
New York
$322K -$6.86K -234 -2%
Morgan Stanley
31
Morgan Stanley
New York
$152K +$37.4K +1,275 +29%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$31K -$2.93K -100 -8%
Wells Fargo
33
Wells Fargo
California
$11K – – –
TRCT
34
Tower Research Capital (TRC)
New York
$8K +$8.36K +285 +1,900%
Creative Planning
35
Creative Planning
Kansas
$7K -$281K -9,600 -97%
DADC
36
D.A. Davidson & Co
Montana
$7K – – –
GWM
37
Geneos Wealth Management
Colorado
$6K – – –
AIM
38
Advantage Investment Management
Iowa
$5K – – –
NIP
39
Nicholas Investment Partners
California
– -$513K -18,662 Closed
TI
40
Trexquant Investment
Connecticut
– -$347K -12,628 Closed
DAM
41
Deltec Asset Management
New York
– -$330K -12,000 Closed
Bank of New York Mellon
42
Bank of New York Mellon
New York
– -$224K -8,130 Closed
FNYS
43
First New York Securities
New York
– -$64.4K -2,341 Closed
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
– -$54K -1,973 Closed
Citigroup
45
Citigroup
New York
– -$1K -37 Closed
1
2

CLLS Hedge Fund Activity: Q2 2016 in Review

38 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2016, worth a combined $184M — up 4.5% from $176M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of CLLS and 2 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 15 added.

The largest buyer was Perceptive Advisors, adding an estimated $5.29M. The largest seller was Vident Investment Advisory, cutting an estimated $722K.

  • 38 institutional investors held Cellectis (CLLS) as of Q2 2016, down from 44 in Q1 2016.
  • Funds reported $184M of Cellectis stock for Q2 2016, up 4.5% quarter-over-quarter.
  • 2 funds opened new Cellectis positions in Q2 2016 and 7 closed out, a net change of -5 holders.
  • The largest Cellectis buyer in Q2 2016 was Perceptive Advisors, an estimated $5.29M added.
  • The largest Cellectis seller in Q2 2016 was Vident Investment Advisory, an estimated $722K sold.

Based on aggregated 13F filings for Q2 2016.